NCT03150693 2026-03-02Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaAlliance for Clinical Trials in OncologyPhase 3 Suspended310 enrolled